Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
While most GLP-1 injections can be stopped abruptly from a safety perspective, the effects on appetite, blood sugar, and weight may return gradually
Some plans may cover these treatments when prescribed for a qualifying diagnosis, such as obesity (BMI 30) or overweight (BMI 27) with a weight-related comorbidity
It targets areas of the brain that regulate appetite and food intake
Because retatrutide activates multiple hormone pathways, some people may experience more pronounced gastrointestinal symptoms
Side Effects of Qsymia for Weight Loss The most common side effects, reported by 5% or more of patients, include: Paresthesia (tingling in hands, feet, or face), reported by about 20% of patients Dry mouth Insomnia , especially if taken later in the day Dizziness Constipation Taste changes , particularly with carbonated drinks Mood changes , including irritability or low mood Difficulty concentrating or brain fog with higher doses of topiramate Less common but more serious risks include: Increased heart rate Acute glaucoma (rare, but requires immediate discontinuation) Kidney stones Birth defects (Qsymia is in a Risk Evaluation and Mitigation Strategy or REMS program, due to teratogenicity risk) Qsymia should not be used during pregnancy, in patients with glaucoma, hyperthyroidism or those taking MAOIs
The major ROS-producing systems include mitochondrial electron transport chain dysfunction, cytochrome P450 2E1 (CYP2E1) activity, and NADPH oxidase (NOX) enzymes [98]
